CONVERTIBLE PROMISSORY NOTE PURCHASE AGREEMENTConvertible Promissory Note Purchase Agreement • October 8th, 2021 • 4Front Ventures Corp. • Medicinal chemicals & botanical products • New York
This Convertible Promissory Note Purchase Agreement, dated as of October 6, 2021 (this “Agreement”), is entered into by and among 4Front Ventures Corp., a British Columbia corporation (the “Company”), Navy Capital Green Fund, LP, a Delaware limited partnership (the “Lead Investor”), Navy Capital Green Co-Invest Fund, LLC, a Delaware limited liability company (“Navy Co-Invest”) and HI 4Front, LLC, a Delaware limited liability company (“HI 4Front” and, together with the Lead Investor and Navy Co-Invest, the “Investors”).
MEMBERSHIP INTEREST PURCHASE AGREEMENTMembership Interest Purchase Agreement • October 8th, 2021 • 4Front Ventures Corp. • Medicinal chemicals & botanical products • Massachusetts
This Membership Interest Purchase Agreement (this “Agreement”), dated as of October 6, 2021, is entered into by and among Kenneth V. Stevens, an individual residing in the Commonwealth of Massachusetts (“Seller”), Mission Partners RE, LLC, a Delaware limited liability company (“Buyer”), and 4Front Ventures Corp., a corporation amalgamated under the Laws of the Province of British Columbia, Canada (“4Front”).
PROMISSORY NOTE AND PLEDGE AGREEMENTPromissory Note and Pledge Agreement • February 3rd, 2022 • 4Front Ventures Corp. • Medicinal chemicals & botanical products • Massachusetts
For value received, 4Front Ventures Corp., a corporation amalgamated under the laws of the Province of British Columbia, Canada (“4Front” or “Maker”), promises to pay to the order of Kenneth V. Stevens, an individual residing in the Commonwealth of Massachusetts (“Holder”), or his permitted transferees or assigns, in lawful money of the United States of America and in immediately available funds, the aggregate principal amount of Two Million Dollars and No/100 Cents (USD$2,000,000.00), together with interest thereon calculated as provided below, in accordance with, and subject to, the provisions of this Promissory Note and Pledge Agreement (this “Note and Pledge”).
AMENDED AND RESTATED SECURITIES PURCHASE AGREEMENT THIS AGREEMENT is made as of the 31st day of July, 2019.Securities Purchase Agreement • June 30th, 2020 • 4Front Ventures Corp. • Medicinal chemicals & botanical products • New York
THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “U.S. SECURITIES ACT”) OR UNDER ANY STATE SECURITIES LAWS, AND THE SECURITIES REPRESENTED HEREBY MAY BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED ONLY (A) TO THE COMPANY, (B) OUTSIDE THE UNITED STATES IN ACCORDANCE WITH RULE 904 OF REGULATION S UNDER THE U.S. SECURITIES ACT IN COMPLIANCE WITH APPLICABLE LOCAL LAWS AND REGULATIONS, (C) PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE U.S. SECURITIES ACT PROVIDED BY (1) RULE 144 THEREUNDER, IF AVAILABLE, OR (2) 144A THEREUNDER, IF AVAILABLE, AND, IN EACH CASE, IN COMPLIANCE WITH APPLICABLE U.S. STATE SECURITIES LAWS, OR (D) WITH THE PRIOR WRITTEN CONSENT OF THE COMPANY, PURSUANT TO ANOTHER EXEMPTION FROM REGISTRATION UNDER THE U.S. SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS, PROVIDED THAT, IN THE CASE OF (C)(1) AND (D) ABOVE, AN OPINION OF COUNSEL OF RECOGNIZED STANDING IN FORM AND SUBSTANCE REASON
AMENDED AND RESTATED LOAN AND SECURITY AGREEMENTLoan and Security Agreement • April 15th, 2024 • 4Front Ventures Corp. • Medicinal chemicals & botanical products
FIRST AMENDMENT TO AGREEMENT AND PLAN OF MERGERAgreement and Plan of Merger • February 3rd, 2022 • 4Front Ventures Corp. • Medicinal chemicals & botanical products • Massachusetts
THIS FIRST AMENDMENT TO AGREEMENT AND PLAN OF MERGER (this “Amendment”), dated as of January 28, 2022, is entered into among New England Cannabis Corporation, Inc., a Massachusetts corporation (the “Company”), Kenneth V. Stevens, an individual residing in the Commonwealth of Massachusetts (the “Shareholder”), 4Front Ventures Corp., a corporation amalgamated under the Laws of the Province of British Columbia, Canada (“4Front”), and 4Front NECC Acquisition Co., a Massachusetts corporation (“Merger Sub”). All initially capitalized terms used but not defined in this Amendment shall have the meanings assigned to such terms in the Merger Agreement (as defined below).
AGREEMENT AND PLAN OF MERGERMerger Agreement • October 8th, 2021 • 4Front Ventures Corp. • Medicinal chemicals & botanical products • Massachusetts
This Agreement and Plan of Merger (this “Agreement”), dated as of October 6, 2021, is entered into among New England Cannabis Corporation, Inc., a Massachusetts corporation (the “Company”), Kenneth V. Stevens, an individual residing in the Commonwealth of Massachusetts (the “Shareholder”), 4Front Ventures Corp., a corporation amalgamated under the Laws of the Province of British Columbia, Canada (“4Front”), and 4Front NECC Acquisition Co., a Massachusetts corporation (“Merger Sub”).
FIRST AMENDMENT TO MEMBERSHIP INTEREST PURCHASE AGREEMENTMembership Interest Purchase Agreement • February 3rd, 2022 • 4Front Ventures Corp. • Medicinal chemicals & botanical products • Massachusetts
THIS FIRST AMENDMENT TO MEMBERSHIP INTEREST PURCHASE AGREEMENT (this “Amendment”), dated as of January 28, 2022, is entered into among Kenneth V. Stevens, an individual residing in the Commonwealth of Massachusetts (“Seller”), 4Front Ventures Corp., a corporation amalgamated under the Laws of the Province of British Columbia, Canada (“4Front”), and Mission Partners RE, LLC, a Delaware limited liability company (“Buyer”). All initially capitalized terms used but not defined in this Amendment shall have the meanings assigned to such terms in the Purchase Agreement (as defined below).
MEMBERSHIP INTEREST PURCHASE AGREEMENTMembership Interest Purchase Agreement • April 7th, 2021 • 4Front Ventures Corp. • Medicinal chemicals & botanical products • Delaware
This Membership Interest Purchase Agreement, dated as of April 30, 2020 (this “Agreement”), is entered into by and among (i) MLH NE Pennsylvania, LLC, a Delaware limited liability company (“Buyer”), (ii) Mission Pennsylvania II, LLC, a Pennsylvania limited liability company (the “Company”), (iii) Linchpin Investors, LLC, a Delaware limited liability company (the “RE Seller”) and 326 Bear Creek Commons LLC, a Delaware limited liability company (the “RE Company”), and (iv) 4Front Ventures Corp., a corporation amalgamated under the laws of the Province of British Columbia (“Seller Parent”), Mission Mercury, LLC, a Delaware limited liability company (“Mission Mercury”) and PL Pennsylvania Dispensary, LLC, a Pennsylvania limited liability company (“PL PA” and together with Mission Mercury and the RE Seller, the “Sellers” and each, a “Seller”). The Seller Parent and the Sellers are sometimes referred to herein as the “Seller Parties.” The Buyer, the Company, the RE Company and the Seller Par
SEPARATION AGREEMENT AND RELEASESeparation Agreement • April 7th, 2021 • 4Front Ventures Corp. • Medicinal chemicals & botanical products • Arizona
This Separation Agreement and Release (this “Agreement”) is made as a compromise and release between 4Front Ventures Corp., a corporation amalgamated under the laws of the Province of British Columbia, Canada (the “Company”), and Joshua N. Rosen, an individual residing in the State of Arizona (“Employee”), in the complete, final, and binding settlement of all claims and potential claims, if any, with respect to their employment relationship.
AMENDED AND RESTATED CONSULTING AGREEMENTConsulting Agreement • April 7th, 2021 • 4Front Ventures Corp. • Medicinal chemicals & botanical products • Washington
This Amended and Restated Consulting Agreement, dated as of November 12, 2020 (this “Agreement”), is made and entered into by and among Ag-Grow Imports, LLC, a Washington limited liability company (the “Company”), 4Front Ventures Corp., a corporation amalgamated under the laws of the Province of British Columbia, Canada (“4Front”), and Maha Consulting LLC, a Puerto Rican limited liability company (“Consultant”).
TERMINATION AGREEMENTTermination Agreement • April 7th, 2021 • 4Front Ventures Corp. • Medicinal chemicals & botanical products • Maryland
This Termination Agreement (the “Termination Agreement”), dated as of August 11, 2020 (the “Effective Date”), is by and among Premium Medicine of Maryland, LLC, a Maryland limited liability company (“Premium”), Silver Spring Consulting Group, LLC, a Delaware limited liability company (“SSCG”), Eric Steenstra, an individual resident in the State of Maryland (“Mr. Steenstra”), Dawn Steenstra, an individual resident in the State of Maryland (“Ms. Steenstra”), 4Front Advisors, LLC, an Arizona limited liability company (“4Front Advisors”), 4Front PM InvestCo, LLC, a Maryland limited liability company (“4Front InvestCo”), 4Front Ventures Corp., a corporation amalgamated under the laws of the Province of British Columbia (“4Front”), and Bayside Partners, LLC, a Maryland limited liability company (“Bayside”). Each of Premium, SSCG, Mr. Steenstra, Ms. Steenstra, 4Front Advisors, 4Front InvestCo and Bayside is referred to herein as a “Party” and collectively as the “Parties”.
INDEMNITY AGREEMENT This Agreement is made effective as of the __rd day of ___________ 20__;Indemnity Agreement • June 30th, 2020 • 4Front Ventures Corp. • Medicinal chemicals & botanical products • British Columbia
SEPARATION AGREEMENT AND RELEASESeparation Agreement • April 7th, 2021 • 4Front Ventures Corp. • Medicinal chemicals & botanical products • Arizona
This Separation Agreement and Release (this “Agreement”) is made as a compromise and release between 4Front Ventures Corp., a corporation amalgamated under the laws of the Province of British Columbia, Canada (the “Company”), and Nicolle Dorsey, an individual residing in the State of Arizona (“Employee”), in the complete, final, and binding settlement of all claims and potential claims, if any, with respect to their employment relationship.
SECOND ADDENDUM TO MEMBERSHIP INTEREST PURCHASE AGREEMENTMembership Interest Purchase Agreement • April 7th, 2021 • 4Front Ventures Corp. • Medicinal chemicals & botanical products
THIS SECOND ADDENDUM (the “Second Addendum”) entered into on August 12, 2020, amends, modifies, supplements and clarifies the terms and conditions of that certain Membership Interest Purchase Agreement (the “Original Agreement”), dated as of January 22, 2020, by and among 4Front Holdings LLC, a Delaware limited liability company (“4F Holdings”), 4Front Arkansas, LLC, a Delaware limited liability company (“4F Arkansas”, and together with 4F Holdings, collectively, the “Seller”), and Denham Investments, LLC, an Arkansas limited liability company (“Buyer”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • June 30th, 2020 • 4Front Ventures Corp. • Medicinal chemicals & botanical products • Arizona
This EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) is entered into and effective as of April 15, 2020 (the “Effective Date”), by and between 4Front Ventures Corp., a British Columbia corporation (the “Company”), and Joshua N. Rosen, an individual residing in the State of Arizona (the “Executive”).
ContractConstruction Loan Agreement • June 30th, 2020 • 4Front Ventures Corp. • Medicinal chemicals & botanical products • Colorado
Exhibit 4.4 CONSTRUCTION LOAN AGREEMENT by and among LINCHPIN INVESTORS, LLC, A Delaware limited liability company And ITS WHOLLY-OWNED SUBSIDIARIES THAT MAY HEREAFTER BECOME PARTIES HERETO, Each as a Borrower, And LI LENDING, LLC a Delaware limited liability company, as Lender,
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • April 7th, 2021 • 4Front Ventures Corp. • Medicinal chemicals & botanical products • Maryland
This Asset Purchase Agreement, dated as of April 30, 2020 (this “Agreement”), is entered into by and among (i) MLH Maryland Operations, LLC, a Delaware limited liability company (“Buyer”), and MLH Hampden Real Estate, LLC, a Delaware limited liability company and a wholly owned subsidiary of Buyer (“RE Buyer” and together with Buyer, the “Buyers”), (ii) Mission Maryland, LLC, a Maryland limited liability company (“Mission Maryland”), Adroit Consulting Group, LLC, a Delaware limited liability company (“Adroit”), Old Line State Consulting Group, LLC, a Delaware limited liability company (“Old Line” and together with Adroit, the “Sellers” and each, a “Seller”), and (iv) 4Front Ventures Corp., a corporation amalgamated under the laws of the Province of British Columbia (“Seller Parent” and together with the Sellers and Mission Maryland, the “Seller Parties”). The Seller Parties and the Buyers are sometimes referred to herein as the “Parties,” and each, a “Party.”
MEMBERSHIP INTEREST PURCHASE AGREEMENTMembership Interest Purchase Agreement • April 7th, 2021 • 4Front Ventures Corp. • Medicinal chemicals & botanical products • Arkansas
effective as of January 22, 2020 (the “Effective Date”), by and among, 4Front Holdings LLC, a Delaware limited liability company (“4F Holdings”), 4Front Arkansas, LLC, a Delaware limited liability company (“4F Arkansas”, and collectively with 4F Holdings the “Seller”), and Denham Investments, LLC, an Arkansas limited liability company (“Buyer”).
LOAN AGREEMENTLoan Agreement • April 15th, 2024 • 4Front Ventures Corp. • Medicinal chemicals & botanical products • New York
SECOND AMENDMENT TO AMENDED AND RESTATED LOAN AND SECURITY AGREEMENTLoan and Security Agreement • February 1st, 2024 • 4Front Ventures Corp. • Medicinal chemicals & botanical products
THIS SECOND AMENDMENT TO THE AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT (this “Amendment”) is made and entered into as of January 29, 2024 by and among (i) LINCHPIN INVESTORS, LLC, a Delaware limited liability company, 401 EAST MAIN STREET LLC, a Delaware limited liability company, IL GROWN MEDICINE LLC, an Illinois limited liability company, 8554 S. COMMERCIAL AVE, LLC, a Delaware limited liability company, 883 HYDE PARK AVE, LLC, a Delaware limited liability company, HEALTHY PHARMS, INC., a Massachusetts corporation, and 4FRONT CALIFORNIA CAPITAL HOLDINGS, INC., a California corporation (each, a “Borrower” and collectively, the “Borrowers”), (ii) 4FRONT VENTURES CORP., a corporation organized under the laws of British Columbia (the “Guarantor” or “4Front Ventures”), (iii) ISLAND GLOBAL HOLDINGS, INC., a California corporation, CAROUSEL BAY, LLC, a California limited liability company, ISLA BUENA VISTA LLC, a California limited liability company, GOLD COAST GARDENS LLC, a Califo
FIRST AMENDMENT TO AGREEMENT AND PLAN OF MERGERAgreement and Plan of Merger • April 22nd, 2022 • 4Front Ventures Corp. • Medicinal chemicals & botanical products
THIS FIRST AMENDMENT TO AGREEMENT AND PLAN OF MERGER (this “Amendment”) is made as of this 8th day of April, 2022, by and among: (i) 4Front Ventures Corp., a British Columbia corporation (the “Company”); (ii) Island Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“Merger Sub”); (iii) Island Global Holdings, Inc., a California corporation (“Island”); and (iv) Navy Capital SR LLC, a Delaware limited liability company, solely in its capacity as the representative of the Island Securityholders (the “Stockholder Representative”). The Company, Merger Sub, Island and the Stockholder Representative are sometimes referred to herein individually as a “Party” and collectively as the “Parties.” All capitalized terms used but not defined herein shall have the meanings given to them in the Agreement (as hereinafter defined).
4FRONT HOLDINGS LLC AND 4FRONT CORP. AND 1196260 B.C. LTD. AND CANNEX CAPITAL HOLDINGS INC. BUSINESS COMBINATION AGREEMENT DATED MARCH 1, 2019Business Combination Agreement • June 30th, 2020 • 4Front Ventures Corp. • Medicinal chemicals & botanical products • British Columbia
STOCK PURCHASE AGREEMENT BY AND AMONG 4FRONT HOLDINGS LLC, PAUL OVERGAAG, NATHANIEL AVERILL, AND HEALTHY PHARMS, INC. November 13, 2018Stock Purchase Agreement • June 30th, 2020 • 4Front Ventures Corp. • Medicinal chemicals & botanical products • Massachusetts
This STOCK PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of November 13, 2018, by and among Healthy Pharms, Inc., a Massachusetts corporation (the “Company”), Paul Overgaag, an individual (“Overgaag”), Nathaniel Averill, an individual (“Averill” and, together with Overgaag, “ Sellers” and each a “Seller”), and 4Front Holdings LLC, a Delaware limited liability company (“Buyer”). Capitalized terms used and not otherwise defined in this Agreement have the meanings set forth in Section 1.1.
LOCK-UP AGREEMENTLock-Up Agreement • August 27th, 2019 • 4Front Ventures Corp. • Medicinal chemicals & botanical products • British Columbia
This LOCK-UP AGREEMENT (this "Agreement") is dated as of the 22nd day of August, 2019, by and among 4Front Ventures Corp., a corporation amalgamated under the laws of the Province of British Columbia (the "Company") and the shareholders of the Company named in Schedule "A" hereto (each, a "Shareholder", together, the "Shareholders", and together with the Company, the "Parties").
LOCK-UP AGREEMENTLock-Up Agreement • June 30th, 2020 • 4Front Ventures Corp. • Medicinal chemicals & botanical products • British Columbia
This LOCK- UP AGREEMENT (this “Agreement”) is dated as of the 22nd day of August, 2019, by and among 4Front Ventures Corp., a corporation amalgamated under the laws of the Province of British Columbia (the “Company”) and the shareholders of the Company named in Schedule “A” hereto (each, a “Shareholder”, together, the “Shareholders”, and together with the Company, the “Parties”).
AGREEMENT AND PLAN OF MERGERMerger Agreement • April 6th, 2022 • 4Front Ventures Corp. • Medicinal chemicals & botanical products • California
THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”) is made and entered into as of March 30, 2022, by and among: (i) 4Front Ventures Corp., a British Columbia corporation (the “Company”); (ii) Island Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“Merger Sub”); (iii) Island Global Holdings, Inc., a California corporation (“Island”); and (iv) Navy Capital SR LLC, a Delaware limited liability company, solely in its capacity as the representative of the Island Securityholders (the “Stockholder Representative”). The Company, Merger Sub, Island and the Stockholder Representative are sometimes referred to herein individually as a “Party” and collectively as the “Parties.” Capitalized terms used in this Agreement are defined in Section 1.
FIRST AMENDMENT TO AMENDED AND RESTATED LOAN AND SECURITY AGREEMENTLoan and Security Agreement • September 1st, 2023 • 4Front Ventures Corp. • Medicinal chemicals & botanical products
THIS FIRST AMENDMENT TO THE AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT (this “Amendment”) is made and entered into as of July 31, 2023 by and among LINCHPIN INVESTORS, LLC, a Delaware limited liability company, 401 EAST MAIN STREET LLC, a Delaware limited liability company, IL GROWN MEDICINE LLC, an Illinois limited liability company, 8554 S. COMMERCIAL AVE, LLC, a Delaware limited liability company, 883 HYDE PARK AVE, LLC, a Delaware limited liability company, HEALTHY PHARMS, INC., a Massachusetts corporation, and 4FRONT CALIFORNIA CAPITAL HOLDINGS, INC., a California corporation (each a Borrower and together referred to herein as a “Borrower” and referred to collectively as the “Borrowers”), ISLAND GLOBAL HOLDINGS, INC., a California corporation, CAROUSEL BAY, LLC, a California limited liability company, ISLA BUENA VISTA LLC, a California limited liability company, GOLD COAST GARDENS LLC, a California limited liability company, ROBOT FARMS INC., a California corporation, HARBOR
FIRST ADDENDUM TO MEMBERSHIP INTEREST PURCHASE AGREEMENTMembership Interest Purchase Agreement • April 7th, 2021 • 4Front Ventures Corp. • Medicinal chemicals & botanical products
THIS FIRST ADDENDUM (the “Addendum”) entered into on March 31, 2020, amends, modifies, supplements and clarifies the terms and conditions of that certain Membership Interest Purchase Agreement (the “Agreement”), dated as of January 22, 2020, by and among 4Front Holdings, LLC, a Delaware limited liability company (“4F Holdings”), 4Front Arkansas, LLC, a Delaware limited liability company (“4F Arkansas”, and together with 4F Holdings, collectively, the “Seller”), and Denham Investments, LLC, an Arkansas limited liability company (“Buyer”). Terms capitalized but not otherwise defined herein shall have the meanings ascribed to them in the Agreement.
LOAN AND SECURITY AGREEMENTLoan and Security Agreement • June 30th, 2020 • 4Front Ventures Corp. • Medicinal chemicals & botanical products • Illinois
This Loan and Security Agreement (this “Loan Agreement”) is made and entered into at Chicago, Illinois, on June 30, 2016, by and between Linchpin Investors LLC, a Delaware limited liability company (“Lender”), and IGM, LLC an Illinois limited liability company (“IGM”), Harborside Illinois Grown Medicine, Inc., an Illinois corporation (“Harborside”), and IL Grown Medicine LLC, an Illinois limited liability company (“Grown Medicine”) [Harborside and Grown Medicine are sometimes collectively referred to as “Borrowers”].
4FRONT VENTURES CORP. SEVERANCE GENERAL WAIVER AND RELEASE AGREEMENT Jerry DerevyannySeverance Agreement • April 7th, 2021 • 4Front Ventures Corp. • Medicinal chemicals & botanical products
CONTRIBUTION AGREEMENTContribution Agreement • June 30th, 2020 • 4Front Ventures Corp. • Medicinal chemicals & botanical products • Delaware
THIS CONTRIBUTION AGREEMENT (this “Agreement”) is made and entered into as of November 13, 2018, by and between 4Front Holdings LLC, a Delaware limited liability company (“Parent”), and Mission Partners USA, LLC, a Delaware limited liability company (“Sub”). The parties hereto are sometimes hereinafter referred to individually as a “Party” and collectively as the “Parties.”
CONSULTING AGREEMENTConsulting Agreement • July 28th, 2023 • 4Front Ventures Corp. • Medicinal chemicals & botanical products • California
This Consulting Agreement (“Agreement”) is made as of July 24, 2023 (the “Effective Date”) between 4Front Ventures Corp. (the “Company”) with its principal place of business and corporate headquarters located at 7010 E. Chauncey Lane, Suite 235, Phoenix, AZ 85054 and Maha Consulting LLC (“Consultant”).
4FRONT VENTURES CORP. SEVERANCE GENERAL WAIVER AND RELEASE AGREEMENT Brad KotanskySeverance Agreement • April 7th, 2021 • 4Front Ventures Corp. • Medicinal chemicals & botanical products
AMENDMENT NO. 1 TO CONVERTIBLE PROMISSORY NOTE PURCHASE AGREEMENTConvertible Promissory Note Purchase Agreement • April 15th, 2024 • 4Front Ventures Corp. • Medicinal chemicals & botanical products • New York
This Amendment No. 1 to Convertible Promissory Note Purchase Agreement (this “Amendment”) is entered into as of October 6, 2023 (the “Effective Date”), by and among 4Front Ventures Corp., a British Columbia corporation (the “Company”) and Navy Capital Green Fund, LP, a Delaware limited partnership (the “Lead Investor”), Navy Capital Green Co- Invest Fund, LLC, a Delaware limited liability company (“Navy Co-Invest”) and HI 4Front, LLC, a Delaware limited liability company (“HI 4Front” and, together with the Lead Investor and Navy Co-Invest, the “Investors”). Reference is made to that certain Convertible Promissory Note Purchase Agreement (the “Purchase Agreement”), dated as of August 6, 2021, by and among the Company and the Investors. Capitalized terms not otherwise defined in this Amendment shall have the meanings ascribed to them in the Purchase Agreement. To the extent set forth herein, this Amendment also modifies the terms and conditions of the existing Notes.
